The transplantation of Wharton's jelly derived mesenchymal stromal cells (WJ-MSCs) possesses therapeutic potential for the treatment of a spinal cord injury (SCI). Generally, the main effect of MSCs is mediated by their paracrine potential. Therefore, application of WJ-MSC derived conditioned media (CM) is an acknowledged approach for how to bypass the limited survival of transplanted cells. In this study, we compared the effect of human WJ-MSCs and their CM in the treatment of SCI in rats. WJ-MSCs and their CM were intrathecally transplanted in the three consecutive weeks following the induction of a balloon compression lesion. Behavioral analyses were carried out up to 9 weeks after the SCI and revealed significant improvement after the treatment with WJ-MSCs and CM, compared to the saline control. Both WJ-MSCs and CM treatment resulted in a higher amount of spared gray and white matter and enhanced expression of genes related to axonal growth. However, only the CM treatment further improved axonal sprouting and reduced the number of reactive astrocytes in the lesion area. On the other hand, WJ-MSCs enhanced the expression of inflammatory and chemotactic markers in plasma, which indicates a systemic immunological response to xenogeneic cell transplantation. Our results confirmed that WJ-MSC derived CM offer an alternative to direct stem cell transplantation for the treatment of SCI.

Charles University 2nd Faculty of Medicine 14220 Prague Czech Republic

Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 14200 Prague Czech Republic

Zobrazit více v PubMed

Machova Urdzikova L., Karova K., Ruzicka J., Kloudova A., Shannon C., Dubisova J., Murali R., Kubinova S., Sykova E., Jhanwar-Uniyal M., et al. The Anti-Inflammatory Compound Curcumin Enhances Locomotor and Sensory Recovery after Spinal Cord Injury in Rats by Immunomodulation. Int. J. Mol. Sci. 2016;17:49. doi: 10.3390/ijms17010049. PubMed DOI PMC

Kubinova S. New trends in spinal cord tissue engineering. Future Neurol. 2015;10:129–145. doi: 10.2217/fnl.14.71. DOI

Pego A.P., Kubinova S., Cizkova D., Vanicky I., Mar F.M., Sousa M.M., Sykova E. Regenerative medicine for the treatment of spinal cord injury: More than just promises? J. Cell. Mol. Med. 2012;16:2564–2582. doi: 10.1111/j.1582-4934.2012.01603.x. PubMed DOI PMC

Fan X., Wang J.Z., Lin X.M., Zhang L. Stem cell transplantation for spinal cord injury: A meta-analysis of treatment effectiveness and safety. Neural. Regen. Res. 2017;12:815–825. PubMed PMC

Cofano F., Boido M., Monticelli M., Zenga F., Ducati A., Vercelli A., Garbossa D. Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy. Int. J. Mol. Sci. 2019;20:2698. doi: 10.3390/ijms20112698. PubMed DOI PMC

Morita T., Sasaki M., Kataoka-Sasaki Y., Nakazaki M., Nagahama H., Oka S., Oshigiri T., Takebayashi T., Yamashita T., Kocsis J.D., et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016;335:221–231. doi: 10.1016/j.neuroscience.2016.08.037. PubMed DOI

Urdzikova L.M., Ruzicka J., LaBagnara M., Karova K., Kubinova S., Jirakova K., Murali R., Sykova E., Jhanwar-Uniyal M., Jendelova P. Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat. Int. J. Mol. Sci. 2014;15:11275–11293. doi: 10.3390/ijms150711275. PubMed DOI PMC

Krupa P., Vackova I., Ruzicka J., Zaviskova K., Dubisova J., Koci Z., Turnovcova K., Urdzikova L.M., Kubinova S., Rehak S., et al. The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application. Int. J. Mol. Sci. 2018;19:1503. doi: 10.3390/ijms19051503. PubMed DOI PMC

Amemori T., Jendelova P., Ruzickova K., Arboleda D., Sykova E. Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. Cytotherapy. 2010;12:212–225. doi: 10.3109/14653240903440103. PubMed DOI

Qu J., Zhang H. Roles of Mesenchymal Stem Cells in Spinal Cord Injury. Stem Cells Int. 2017;2017:5251313. doi: 10.1155/2017/5251313. PubMed DOI PMC

Cizkova D., Devaux S., Le Marrec-Croq F., Franck J., Slovinska L., Blasko J., Rosocha J., Spakova T., Lefebvre C., Fournier I., et al. Modulation properties of factors released by bone marrow stromal cells on activated microglia: An in vitro study. Sci. Rep. 2014;4:7514. doi: 10.1038/srep07514. PubMed DOI PMC

Pires A.O., Mendes-Pinheiro B., Teixeira F.G., Anjo S.I., Ribeiro-Samy S., Gomes E.D., Serra S.C., Silva N.A., Manadas B., Sousa N., et al. Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis. Stem Cells Dev. 2016;25:1073–1083. doi: 10.1089/scd.2016.0048. PubMed DOI

Ferreira J.R., Teixeira G.Q., Santos S.G., Barbosa M.A., Almeida-Porada G., Goncalves R.M. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning. Front. Immunol. 2018;9:2837. doi: 10.3389/fimmu.2018.02837. PubMed DOI PMC

Phelps J., Sanati-Nezhad A., Ungrin M., Duncan N.A., Sen A. Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics. Stem Cells Int. 2018;2018:9415367. doi: 10.1155/2018/9415367. PubMed DOI PMC

Vizoso F.J., Eiro N., Cid S., Schneider J., Perez-Fernandez R. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int. J. Mol. Sci. 2017;18:1852. doi: 10.3390/ijms18091852. PubMed DOI PMC

Teixeira F.G., Carvalho M.M., Panchalingam K.M., Rodrigues A.J., Mendes-Pinheiro B., Anjo S., Manadas B., Behie L.A., Sousa N., Salgado A.J. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson’s Disease. Stem Cells Transl. Med. 2017;6:634–646. doi: 10.5966/sctm.2016-0071. PubMed DOI PMC

Cunningham C.J., Redondo-Castro E., Allan S.M. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J. Cereb. Blood Flow Metab. 2018;38:1276–1292. doi: 10.1177/0271678X18776802. PubMed DOI PMC

Suto N., Mieda T., Iizuka A., Nakamura K., Hirai H. Morphological and Functional Attenuation of Degeneration of Peripheral Neurons by Mesenchymal Stem Cell-Conditioned Medium in Spinocerebellar Ataxia Type 1-Knock-in Mice. CNS Neurosci. 2016;22:670–676. doi: 10.1111/cns.12560. PubMed DOI PMC

Giacoppo S., Thangavelu S.R., Diomede F., Bramanti P., Conti P., Trubiani O., Mazzon E. Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: A key role of IL-37. Faseb J. 2017;31:5592–5608. doi: 10.1096/fj.201700524R. PubMed DOI PMC

Mita T., Furukawa-Hibi Y., Takeuchi H., Hattori H., Yamada K., Hibi H., Ueda M., Yamamoto A. Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer’s disease. Behav. Brain Res. 2015;293:189–197. doi: 10.1016/j.bbr.2015.07.043. PubMed DOI

Cizkova D., Cubinkova V., Smolek T., Murgoci A.N., Danko J., Vdoviakova K., Humenik F., Cizek M., Quanico J., Fournier I., et al. Localized Intrathecal Delivery of Mesenchymal Stromal Cells Conditioned Medium Improves Functional Recovery in a Rat Model of Spinal Cord Injury. Int. J. Mol. Sci. 2018;19:870. doi: 10.3390/ijms19030870. PubMed DOI PMC

Kanekiyo K., Wakabayashi T., Nakano N., Yamada Y., Tamachi M., Suzuki Y., Fukushima M., Saito F., Abe S., Tsukagoshi C., et al. Effects of Intrathecal Injection of the Conditioned Medium from Bone Marrow Stromal Cells on Spinal Cord Injury in Rats. J. Neurotrauma. 2018;35:521–532. doi: 10.1089/neu.2017.5201. PubMed DOI

Cantinieaux D., Quertainmont R., Blacher S., Rossi L., Wanet T., Noel A., Brook G., Schoenen J., Franzen R. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: An original strategy to avoid cell transplantation. PLoS ONE. 2013;8:e69515. doi: 10.1371/journal.pone.0069515. PubMed DOI PMC

Tsai M.J., Liou D.Y., Lin Y.R., Weng C.F., Huang M.C., Huang W.C., Tseng F.W., Cheng H. Attenuating Spinal Cord Injury by Conditioned Medium from Bone Marrow Mesenchymal Stem Cells. J. Clin. Med. 2018;8:23. doi: 10.3390/jcm8010023. PubMed DOI PMC

Liu W., Wang Y., Gong F., Rong Y., Luo Y., Tang P., Zhou Z., Zhou Z., Xu T., Jiang T., et al. Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes. J. Neurotrauma. 2019;36:469–484. doi: 10.1089/neu.2018.5835. PubMed DOI

Lu Y., Zhou Y., Zhang R., Wen L., Wu K., Li Y., Yao Y., Duan R., Jia Y. Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier. Front. Neurosci. 2019;13:209. doi: 10.3389/fnins.2019.00209. PubMed DOI PMC

Huang J.H., Yin X.M., Xu Y., Xu C.C., Lin X., Ye F.B., Cao Y., Lin F.Y. Systemic Administration of Exosomes Released from Mesenchymal Stromal Cells Attenuates Apoptosis, Inflammation, and Promotes Angiogenesis after Spinal Cord Injury in Rats. J. Neurotrauma. 2017;34:3388–3396. doi: 10.1089/neu.2017.5063. PubMed DOI

Haider T., Hoftberger R., Ruger B., Mildner M., Blumer R., Mitterbauer A., Buchacher T., Sherif C., Altmann P., Redl H., et al. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. Exp. Neurol. 2015;267:230–242. doi: 10.1016/j.expneurol.2015.03.013. PubMed DOI

Gu M., Gao Z., Li X., Guo L., Lu T., Li Y., He X. Conditioned medium of olfactory ensheathing cells promotes the functional recovery and axonal regeneration after contusive spinal cord injury. Brain Res. 2017;1654:43–54. doi: 10.1016/j.brainres.2016.10.023. PubMed DOI

Cheng Z., Bosco D.B., Sun L., Chen X., Xu Y., Tai W., Didier R., Li J., Fan J., He X., et al. Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery. Cell Transpl. 2017;26:469–482. doi: 10.3727/096368916X693473. PubMed DOI PMC

Amable P.R., Teixeira M.V., Carias R.B., Granjeiro J.M., Borojevic R. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly. Stem Cell Res. Ther. 2014;5:53. doi: 10.1186/scrt442. PubMed DOI PMC

Tukmachev D., Forostyak S., Koci Z., Zaviskova K., Vackova I., Vyborny K., Sandvig I., Sandvig A., Medberry C.J., Badylak S.F., et al. Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair. Tissue Eng. Part A. 2016;22:306–317. doi: 10.1089/ten.tea.2015.0422. PubMed DOI PMC

Zaviskova K., Tukmachev D., Dubisova J., Vackova I., Hejcl A., Bystronova J., Pravda M., Scigalkova I., Sulakova R., Velebny V., et al. Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair. J. Biomed. Mater. Res. A. 2018;106:1129–1140. doi: 10.1002/jbm.a.36311. PubMed DOI

Hsieh J.Y., Wang H.W., Chang S.J., Liao K.H., Lee I.H., Lin W.S., Wu C.H., Lin W.Y., Cheng S.M. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS ONE. 2013;8:e72604. doi: 10.1371/journal.pone.0072604. PubMed DOI PMC

Donders R., Bogie J.F., Ravanidis S., Gervois P., Vanheusden M., Marée R., Schrynemackers M., Hubert J.M., Jef Pinxteren S., Gijbels K., et al. Human Wharton’s Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells. Stem Cells Dev. 2018;27:65–84. doi: 10.1089/scd.2017.0029. PubMed DOI

Ruzicka J., Urdzikova L.M., Kloudova A., Amin A.G., Vallova J., Kubinova S., Schmidt M.H., Jhanwar-Uniyal M., Jendelova P. Anti-inflammatory compound curcumin and mesenchymal stem cells in the treatment of spinal cord injury in rats. Acta Neurobiol. Exp. 2018;78:358–374. doi: 10.21307/ane-2018-035. PubMed DOI

Kusuma G.D., Carthew J., Lim R., Frith J.E. Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect. Stem Cells Dev. 2017;26:617–631. doi: 10.1089/scd.2016.0349. PubMed DOI

Petrenko Y., Sykova E., Kubinova S. The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids. Stem Cell Res. Ther. 2017;8:94. doi: 10.1186/s13287-017-0558-6. PubMed DOI PMC

Aghababazadeh M., Kerachian M.A. Cell fasting: Cellular response and application of serum starvation. J. Nutr. Fasting Health. 2014;2:147–150.

Russell F.D., Hamilton K.D. Nutrient deprivation increases vulnerability of endothelial cells to proinflammatory insults. Free Radic. Biol. Med. 2014;67:408–415. doi: 10.1016/j.freeradbiomed.2013.12.007. PubMed DOI

Giampa C., Alvino A., Magatti M., Silini A.R., Cardinale A., Paldino E., Fusco F.R., Parolini O. Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington’s disease. J. Cell Mol. Med. 2019;23:1581–1592. doi: 10.1111/jcmm.14113. PubMed DOI PMC

Duarte A.I., Proenca T., Oliveira C.R., Santos M.S., Rego A.C. Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes. 2006;55:2863–2870. doi: 10.2337/db06-0030. PubMed DOI

Antonios J.P., Farah G.J., Cleary D.R., Martin J.R., Ciacci J.D., Pham M.H. Immunosuppressive mechanisms for stem cell transplant survival in spinal cord injury. Neurosurg. Focus. 2019;46:E9. doi: 10.3171/2018.12.FOCUS18589. PubMed DOI

Lankford K.L., Arroyo E.J., Nazimek K., Bryniarski K., Askenase P.W., Kocsis J.D. Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord. PLoS ONE. 2018;13:e0190358. doi: 10.1371/journal.pone.0190358. PubMed DOI PMC

Kitamura K., Nagoshi N., Tsuji O., Matsumoto M., Okano H., Nakamura M. Application of Hepatocyte Growth Factor for Acute Spinal Cord Injury: The Road from Basic Studies to Human Treatment. Int. J. Mol. Sci. 2019;20:1054. doi: 10.3390/ijms20051054. PubMed DOI PMC

Harvey A.R., Lovett S.J., Majda B.T., Yoon J.H., Wheeler L.P., Hodgetts S.I. Neurotrophic factors for spinal cord repair: Which, where, how and when to apply, and for what period of time? Brain Res. 2015;1619:36–71. doi: 10.1016/j.brainres.2014.10.049. PubMed DOI

Vackova I., Czernekova V., Tomanek M., Navratil J., Mosko T., Novakova Z. Absence of maternal cell contamination in mesenchymal stromal cell cultures derived from equine umbilical cord tissue. Placenta. 2014;35:655–657. doi: 10.1016/j.placenta.2014.04.005. PubMed DOI

Vanicky I., Urdzikova L., Saganova K., Cizkova D., Galik J. A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat. J. Neurotrauma. 2001;18:1399–1407. doi: 10.1089/08977150152725687. PubMed DOI

Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma. 1995;12:1–21. doi: 10.1089/neu.1995.12.1. PubMed DOI

Goldstein L.B. Effects of bilateral and unilateral locus coeruleus lesions on beam-walking recovery after subsequent unilateral sensorimotor cortex suction-ablation in the rat. Restor. Neurol. Neurosci. 1997;11:55–63. PubMed

Storage conditions affect the composition of the lyophilized secretome of multipotent mesenchymal stromal cells

Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis

Human Wharton's Jelly-Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials

A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential